首页 > 最新文献

3 Biotech最新文献

英文 中文
Silybum marianum extract as a next-generation multifunctional therapeutic: potent antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm activities validated by phytochemical profiling and molecular docking. 水飞蓟提取物作为新一代多功能治疗药物:有效的抗氧化、抗糖尿病、抗菌、抗炎和抗生物膜活性,经植物化学分析和分子对接验证。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-10 DOI: 10.1007/s13205-025-04636-4
Muhammad Tahir Akhtar, Mubshara Saadia, Muhammad Imran Irfan

The rising burden of diabetes, oxidative stress, and antimicrobial resistance underscores the need for safe, multifunctional therapeutics. This study explores the antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm properties of Silybum marianum (S. marianum) L. Gaertn. acetic acid extract, complemented by phytochemical profiling and molecular docking. The extract of S. marianum exhibited strong multifunctional bioactivity supported by in vitro and in silico analyses. Antioxidant evaluation (DPPH, ABTS, FRAP) revealed dose-dependent radical scavenging, achieving up to 92.5% inhibition at 1000 µg/mL and a high ferric-reducing capacity (105.6 µM Fe²⁺ equivalents). The extract significantly inhibited α-amylase and α-glucosidase, confirming its antidiabetic potential. In antimicrobial assays, notable activity was observed against Bacillus subtilis (15.2 mm) and Staphylococcus aureus (14.6 mm), with moderate effects on Gram-negative and fungal strains. The extract also showed over 85% inhibition of S. aureus biofilm formation, suggesting interference with quorum sensing and EPS matrix synthesis. Anti-inflammatory assays demonstrated up to 91.2% inhibition of protein denaturation and 86.7% red blood cell membrane stabilization, comparable to indomethacin. Macrophage-based cellular studies confirmed suppression of nitric oxide and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) with > 85% cell viability. GC-MS analysis identified major bioactives including D-arabinitol, chalcone derivatives, and isoquinoline compounds, which were strongly bound to key targets in docking studies-α-amylase, DNA gyrase, COX-2, and NADPH oxidase (binding energies - 9.0 to - 9.9 kcal/mol). These results collectively highlight S. marianum as a biocompatible source of multifunctional phytochemicals with antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm properties, supporting its potential for nutraceutical and therapeutic applications.

糖尿病、氧化应激和抗微生物药物耐药性的负担日益加重,这凸显了对安全、多功能治疗方法的需求。本研究探讨了水飞蓟(S. marianum) L. Gaertn的抗氧化、降糖、抗菌、抗炎和抗生物膜等特性。乙酸提取,辅以植物化学分析和分子对接。体外和体内分析结果表明,菟丝子提取物具有较强的多功能生物活性。抗氧化评估(DPPH, ABTS, FRAP)显示出剂量依赖性的自由基清除作用,在1000µg/mL时达到92.5%的抑制作用,并且具有高铁还原能力(105.6µM Fe 2 +当量)。显著抑制α-淀粉酶和α-葡萄糖苷酶,证实了其抗糖尿病作用。在抗菌试验中,观察到对枯草芽孢杆菌(15.2 mm)和金黄色葡萄球菌(14.6 mm)的显著活性,对革兰氏阴性和真菌菌株有中等作用。该提取物对金黄色葡萄球菌生物膜形成的抑制作用超过85%,表明其干扰了群体感应和EPS基质的合成。抗炎实验显示蛋白变性抑制率高达91.2%,红细胞膜稳定率高达86.7%,与吲哚美辛相当。基于巨噬细胞的研究证实,>抑制一氧化氮和促炎细胞因子(TNF-α, IL-6, IL-1β),细胞存活率为85%。GC-MS分析鉴定出主要的生物活性物质包括d -阿拉伯糖醇、查尔酮衍生物和异喹啉化合物,这些化合物与对接研究中的关键靶点-α-淀粉酶、DNA旋切酶、COX-2和NADPH氧化酶紧密结合(结合能- 9.0至- 9.9 kcal/mol)。这些结果共同强调了南芥作为一种具有抗氧化、抗糖尿病、抗菌、抗炎和抗生物膜特性的多功能植物化学物质的生物相容性来源,支持其在营养保健和治疗方面的应用潜力。
{"title":"<i>Silybum marianum</i> extract as a next-generation multifunctional therapeutic: potent antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm activities validated by phytochemical profiling and molecular docking.","authors":"Muhammad Tahir Akhtar, Mubshara Saadia, Muhammad Imran Irfan","doi":"10.1007/s13205-025-04636-4","DOIUrl":"https://doi.org/10.1007/s13205-025-04636-4","url":null,"abstract":"<p><p>The rising burden of diabetes, oxidative stress, and antimicrobial resistance underscores the need for safe, multifunctional therapeutics. This study explores the antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm properties of <i>Silybum marianum</i> (<i>S. marianum</i>) L. Gaertn. acetic acid extract, complemented by phytochemical profiling and molecular docking. The extract of <i>S. marianum</i> exhibited strong multifunctional bioactivity supported by in vitro and in silico analyses. Antioxidant evaluation (DPPH, ABTS, FRAP) revealed dose-dependent radical scavenging, achieving up to 92.5% inhibition at 1000 µg/mL and a high ferric-reducing capacity (105.6 µM Fe²⁺ equivalents). The extract significantly inhibited α-amylase and α-glucosidase, confirming its antidiabetic potential. In antimicrobial assays, notable activity was observed against <i>Bacillus subtilis</i> (15.2 mm) and <i>Staphylococcus aureus</i> (14.6 mm), with moderate effects on Gram-negative and fungal strains. The extract also showed over 85% inhibition of <i>S. aureus</i> biofilm formation, suggesting interference with quorum sensing and EPS matrix synthesis. Anti-inflammatory assays demonstrated up to 91.2% inhibition of protein denaturation and 86.7% red blood cell membrane stabilization, comparable to indomethacin. Macrophage-based cellular studies confirmed suppression of nitric oxide and pro-inflammatory cytokines (TNF-α, IL-6, IL-1β) with > 85% cell viability. GC-MS analysis identified major bioactives including D-arabinitol, chalcone derivatives, and isoquinoline compounds, which were strongly bound to key targets in docking studies-α-amylase, DNA gyrase, COX-2, and NADPH oxidase (binding energies - 9.0 to - 9.9 kcal/mol). These results collectively highlight <i>S. marianum</i> as a biocompatible source of multifunctional phytochemicals with antioxidant, antidiabetic, antimicrobial, anti-inflammatory, and anti-biofilm properties, supporting its potential for nutraceutical and therapeutic applications.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"26"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12696228/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145754971","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Human umbilical cord plasma derived exosome inhibit the NLRP3 inflammasome and neuro-apoptosis in traumatic spinal cord injury model. 人脐带血浆源性外泌体对外伤性脊髓损伤模型中NLRP3炎性体和神经细胞凋亡的抑制作用
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-20 DOI: 10.1007/s13205-025-04660-4
Hadise Taheri, Hamid Reza Mosleh, Leila Darabi, Shima Jahanbaz, Hooman Kazemi Mirni, Reza Mastery Farahani, Abbas Aliaghaei, Hamid Nazarian, Reza Bahar, Maral Hasanzadeh, Foozhan Tahmasebinia, Amirreza Beirami, Hojjat-Allah Abbaszadeh, Shahram Darabi

Spinal cord injury (SCI) causes severe functional impairments and involves both primary mechanical damage and secondary inflammation. Exosomes from human umbilical cord blood (HUCB) are emerging as promising therapies due to their bioactive components that regulate inflammation and support repair. Thirty-two male rats were randomly divided into four groups: Group A (laminectomy), Group B (contusion), Group C (contusion + PBS), and Group D (contusion + HUCB-exosomes). Contusion injuries were induced using the New York University (NYU) impactor method. HUCB-derived exosomes were extracted and confirmed using scanning electron microscopy (SEM), transmission electron microscopy (TEM), surface markers CD81 and CD9 via flowcytometry, along with dynamic light scattering (DLS), and zeta potential analysis. HUCB-exosomes were administered without prior in vitro expansion; 30 minutes' post-injury, Group D received 100 µg of HUCB-exosomes via tail vein injection for one week. Motor and behavioral functions were assessed using the Basso, Beattie, and Bresnahan (BBB) scale, narrow beam test (NBT), rotarod test, and open-field test. Western blotting was performed eight weeks' post-injury to analyze changes in inflammatory cytokines, and histological changes were assessed via H&E staining. HUCB-exosome administration significantly enhanced functional recovery in SCI rats, as evidenced by higher BBB scores, improved narrow beam, rotarod, and open-field performances compared with PBS and contusion groups. Histological analysis showed reduced cavity formation, increased neuronal density, and decreased gliosis in the exosome-treated group. Western blot results revealed marked downregulation of TNF-α, NLRP3, and GFAP expression. Additionally, exosome therapy restored antioxidant balance by reducing ROS and GSSG levels while elevating GSH, and immunohistochemistry confirmed reduced expression of apoptotic and autophagy markers. This study highlights the therapeutic potential of HUCB-derived exosomes in SCI, demonstrating their ability to attenuate inflammation and promote functional recovery. These findings support HUCB-exosomes as a promising, non-cell-based treatment strategy for SCI.

脊髓损伤(SCI)可引起严重的功能损伤,包括原发性机械损伤和继发性炎症。人类脐带血外泌体(huhb)因其具有调节炎症和支持修复的生物活性成分而成为一种有前景的治疗方法。将32只雄性大鼠随机分为4组:A组(椎板切除术)、B组(挫伤)、C组(挫伤+ PBS)、D组(挫伤+ hucb外泌体)。采用纽约大学(NYU)冲击器法诱导挫伤。通过扫描电镜(SEM)、透射电镜(TEM)、流式细胞术表面标记CD81和CD9、动态光散射(DLS)和zeta电位分析提取hub衍生的外泌体并对其进行确认。在没有事先体外扩增的情况下给予hub外泌体;损伤后30分钟,D组尾静脉注射hub外泌体100µg,持续1周。运动和行为功能采用Basso, Beattie, and Bresnahan (BBB)量表、窄束测试(NBT)、旋转杆测试和空地测试进行评估。伤后8周采用Western blotting分析炎症细胞因子变化,H&E染色评估组织学变化。与PBS组和挫伤组相比,hucb外泌体给药显著增强了SCI大鼠的功能恢复,BBB评分更高,窄束、旋转杆和开阔场地表现得到改善。组织学分析显示,外泌体处理组空腔形成减少,神经元密度增加,胶质瘤减少。Western blot结果显示TNF-α、NLRP3和GFAP表达明显下调。此外,外泌体治疗通过降低ROS和GSSG水平,同时升高GSH来恢复抗氧化平衡,免疫组织化学证实凋亡和自噬标志物的表达减少。这项研究强调了hub来源的外泌体在脊髓损伤中的治疗潜力,证明了它们减轻炎症和促进功能恢复的能力。这些发现支持hub外泌体作为一种有希望的、非细胞基础的脊髓损伤治疗策略。
{"title":"Human umbilical cord plasma derived exosome inhibit the NLRP3 inflammasome and neuro-apoptosis in traumatic spinal cord injury model.","authors":"Hadise Taheri, Hamid Reza Mosleh, Leila Darabi, Shima Jahanbaz, Hooman Kazemi Mirni, Reza Mastery Farahani, Abbas Aliaghaei, Hamid Nazarian, Reza Bahar, Maral Hasanzadeh, Foozhan Tahmasebinia, Amirreza Beirami, Hojjat-Allah Abbaszadeh, Shahram Darabi","doi":"10.1007/s13205-025-04660-4","DOIUrl":"https://doi.org/10.1007/s13205-025-04660-4","url":null,"abstract":"<p><p>Spinal cord injury (SCI) causes severe functional impairments and involves both primary mechanical damage and secondary inflammation. Exosomes from human umbilical cord blood (HUCB) are emerging as promising therapies due to their bioactive components that regulate inflammation and support repair. Thirty-two male rats were randomly divided into four groups: Group A (laminectomy), Group B (contusion), Group C (contusion + PBS), and Group D (contusion + HUCB-exosomes). Contusion injuries were induced using the New York University (NYU) impactor method. HUCB-derived exosomes were extracted and confirmed using scanning electron microscopy (SEM), transmission electron microscopy (TEM), surface markers CD81 and CD9 via flowcytometry, along with dynamic light scattering (DLS), and zeta potential analysis. HUCB-exosomes were administered without prior in vitro expansion; 30 minutes' post-injury, Group D received 100 µg of HUCB-exosomes via tail vein injection for one week. Motor and behavioral functions were assessed using the Basso, Beattie, and Bresnahan (BBB) scale, narrow beam test (NBT), rotarod test, and open-field test. Western blotting was performed eight weeks' post-injury to analyze changes in inflammatory cytokines, and histological changes were assessed via H&E staining. HUCB-exosome administration significantly enhanced functional recovery in SCI rats, as evidenced by higher BBB scores, improved narrow beam, rotarod, and open-field performances compared with PBS and contusion groups. Histological analysis showed reduced cavity formation, increased neuronal density, and decreased gliosis in the exosome-treated group. Western blot results revealed marked downregulation of TNF-α, NLRP3, and GFAP expression. Additionally, exosome therapy restored antioxidant balance by reducing ROS and GSSG levels while elevating GSH, and immunohistochemistry confirmed reduced expression of apoptotic and autophagy markers. This study highlights the therapeutic potential of HUCB-derived exosomes in SCI, demonstrating their ability to attenuate inflammation and promote functional recovery. These findings support HUCB-exosomes as a promising, non-cell-based treatment strategy for SCI.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"33"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718286/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809134","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
FBXW4 suppresses the proliferation and migration of lung adenocarcinoma cells by inhibiting PKNOX2 promoter methylation. FBXW4通过抑制PKNOX2启动子甲基化抑制肺腺癌细胞的增殖和迁移。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-20 DOI: 10.1007/s13205-025-04646-2
Bin Qu, Yuxi Ren, Haoming Shen, Lisha Sun

This study aimed to elucidate the molecular mechanism by which FBXW4 suppresses the progression of lung adenocarcinoma (LUAD). Functional experiments demonstrated that FBXW4 significantly inhibited LUAD cell proliferation, migration, and invasion, while promoting apoptosis. Furthermore, rescue experiments indicated that PKNOX2 silencing partially reversed the tumor-suppressive effects of FBXW4. Mechanistically, FBXW4 facilitated the ubiquitination and degradation of DNMT1, leading to a decrease of methylation of the PKNOX2 promoter. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays confirmed that PKNOX2 transcriptionally activated FHL1 by directly binding to its promoter. In addition, FHL1 was identified as a functional downstream effector responsible for mediating the inhibitory role of PKNOX2 in LUAD malignancy. These findings reveal a previously uncharacterized FBXW4/DNMT1/PKNOX2/FHL1 regulatory axis, providing mechanistic insight into LUAD suppression and potential therapeutic strategies.

Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04646-2.

本研究旨在阐明FBXW4抑制肺腺癌(LUAD)进展的分子机制。功能实验表明,FBXW4显著抑制LUAD细胞的增殖、迁移和侵袭,同时促进细胞凋亡。此外,救援实验表明PKNOX2沉默部分逆转了FBXW4的肿瘤抑制作用。在机制上,FBXW4促进DNMT1的泛素化和降解,导致PKNOX2启动子甲基化降低。染色质免疫沉淀(ChIP)和双荧光素酶报告基因检测证实PKNOX2通过直接结合其启动子激活FHL1。此外,FHL1被鉴定为一种功能性下游效应物,负责介导PKNOX2在LUAD恶性肿瘤中的抑制作用。这些发现揭示了先前未被表征的FBXW4/DNMT1/PKNOX2/FHL1调控轴,为LUAD抑制和潜在的治疗策略提供了机制见解。补充资料:在线版本包含补充资料,下载地址:10.1007/s13205-025-04646-2。
{"title":"FBXW4 suppresses the proliferation and migration of lung adenocarcinoma cells by inhibiting PKNOX2 promoter methylation.","authors":"Bin Qu, Yuxi Ren, Haoming Shen, Lisha Sun","doi":"10.1007/s13205-025-04646-2","DOIUrl":"https://doi.org/10.1007/s13205-025-04646-2","url":null,"abstract":"<p><p>This study aimed to elucidate the molecular mechanism by which FBXW4 suppresses the progression of lung adenocarcinoma (LUAD). Functional experiments demonstrated that FBXW4 significantly inhibited LUAD cell proliferation, migration, and invasion, while promoting apoptosis. Furthermore, rescue experiments indicated that PKNOX2 silencing partially reversed the tumor-suppressive effects of FBXW4. Mechanistically, FBXW4 facilitated the ubiquitination and degradation of DNMT1, leading to a decrease of methylation of the <i>PKNOX2</i> promoter. Chromatin immunoprecipitation (ChIP) and dual-luciferase reporter assays confirmed that <i>PKNOX2</i> transcriptionally activated <i>FHL1</i> by directly binding to its promoter. In addition, FHL1 was identified as a functional downstream effector responsible for mediating the inhibitory role of PKNOX2 in LUAD malignancy. These findings reveal a previously uncharacterized FBXW4/DNMT1/PKNOX2/FHL1 regulatory axis, providing mechanistic insight into LUAD suppression and potential therapeutic strategies.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04646-2.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"34"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12718287/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145809140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation, genomic characterization, fermentation optimization, and enzymatic properties of a chitinase producing strain BM-41. 几丁质酶产生菌株BM-41的分离、基因组鉴定、发酵优化和酶学特性。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-15 DOI: 10.1007/s13205-025-04634-6
Wenwen Zhang, Saimai Ma, Jianmei Dong, Xiaoyun Zhang, Yanjun Ma, Aimei Zhang, Weibao Kong

A novel Streptomyces violaceoruber strain BM-41, isolated from shellfish aquaculture waste, demonstrated potent chitinolytic activity (2.362 U/mL). Whole-genome sequencing revealed a 7.83 Mb genome (72.6% GC) encoding 238 carbohydrate-active enzymes (CAZymes), with 75 glycoside hydrolases (GHs). Significantly, seven chitinase genes were identified: six GH18 family members (ChiA-ChiF) and one GH19 member (Chi2a), displaying greater genetic diversity than S. albidoflavus ATCC 27,414 (45 GHs). Fermentation optimization via single-factor experiments and Box-Behnken response surface methodology yielded optimal enzyme production conditions: 4.5% colloidal chitin, 7 g/L yeast extract, 0.3 g/L MgSO₄, pH 5.0, 30 ℃, and 30% medium volume. This enhanced chitinase activity 2.37-fold (from 0.995 to 2.362 U/mL). Enzymatic characterization showed optimal activity at pH 5.0 and 50 ℃, stability across pH 4-8, and ion-specific modulation: Mg²⁺ and K⁺ increased activity by 25-30%, whereas Cu²⁺ strongly inhibited catalysis. Genomic analysis uncovered a synergistic degradation pathway involving extracellular chitinases (ChiA-ChiF) and 10 key metabolic enzymes, including N-acetylglucosaminidases (EC 3.2.1.52), deacetylases (EC 3.5.1.25), and UDP-N-acetylglucosamine pyrophosphorylases (EC 2.7.7.23). This enzymatic network facilitates efficient conversion of chitin to N-acetylglucosamine monomers and downstream metabolites. The findings contribute to the understanding of S. violaceoruber BM-41 genomic features and its potential as a source of industrially relevant enzymes.

Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04634-6.

从贝类养殖废弃物中分离得到的一株新型紫色链霉菌BM-41具有较强的几丁质降解活性(2.362 U/mL)。全基因组测序结果显示,该基因组全长7.83 Mb (72.6% GC),编码238个碳水化合物活性酶(CAZymes)和75个糖苷水解酶(GHs)。值得注意的是,共鉴定到7个几丁质酶基因:6个GH18家族成员(ChiA-ChiF)和1个GH19家族成员(Chi2a),其遗传多样性高于S. albidoflavus ATCC 27,414(45个GHs)。通过单因素实验和Box-Behnken响应面法优化发酵,得到最佳产酶条件:4.5%胶体甲壳素,7 g/L酵母浸膏,0.3 g/L硫酸镁,pH 5.0, 30℃,30%培养基体积。使几丁质酶活性提高2.37倍(从0.995提高到2.362 U/mL)。酶学表征表明,在pH 5.0和50℃时酶活性最佳,在pH 4-8范围内都很稳定,并且离子特异性调制:Mg 2 +和K +的酶活性提高了25-30%,而Cu 2 +则强烈抑制了催化作用。基因组分析揭示了细胞外几丁质酶(ChiA-ChiF)和10个关键代谢酶的协同降解途径,包括n -乙酰氨基葡萄糖酶(EC 3.2.1.52)、去乙酰化酶(EC 3.5.1.25)和udp - n -乙酰氨基葡萄糖焦磷酸化酶(EC 2.7.7.23)。这种酶网络促进了几丁质有效转化为n -乙酰氨基葡萄糖单体和下游代谢物。这些发现有助于了解s.v violaceoruber BM-41的基因组特征及其作为工业相关酶来源的潜力。补充信息:在线版本包含补充资料,下载地址:10.1007/s13205-025-04634-6。
{"title":"Isolation, genomic characterization, fermentation optimization, and enzymatic properties of a chitinase producing strain BM-41.","authors":"Wenwen Zhang, Saimai Ma, Jianmei Dong, Xiaoyun Zhang, Yanjun Ma, Aimei Zhang, Weibao Kong","doi":"10.1007/s13205-025-04634-6","DOIUrl":"https://doi.org/10.1007/s13205-025-04634-6","url":null,"abstract":"<p><p>A novel <i>Streptomyces violaceoruber</i> strain BM-41, isolated from shellfish aquaculture waste, demonstrated potent chitinolytic activity (2.362 U/mL). Whole-genome sequencing revealed a 7.83 Mb genome (72.6% GC) encoding 238 carbohydrate-active enzymes (CAZymes), with 75 glycoside hydrolases (GHs). Significantly, seven chitinase genes were identified: six GH18 family members (<i>ChiA-ChiF</i>) and one GH19 member (<i>Chi2a</i>), displaying greater genetic diversity than <i>S. albidoflavus</i> ATCC 27,414 (45 GHs). Fermentation optimization via single-factor experiments and Box-Behnken response surface methodology yielded optimal enzyme production conditions: 4.5% colloidal chitin, 7 g/L yeast extract, 0.3 g/L MgSO₄, pH 5.0, 30 ℃, and 30% medium volume. This enhanced chitinase activity 2.37-fold (from 0.995 to 2.362 U/mL). Enzymatic characterization showed optimal activity at pH 5.0 and 50 ℃, stability across pH 4-8, and ion-specific modulation: Mg²⁺ and K⁺ increased activity by 25-30%, whereas Cu²⁺ strongly inhibited catalysis. Genomic analysis uncovered a synergistic degradation pathway involving extracellular chitinases (<i>ChiA-ChiF</i>) and 10 key metabolic enzymes, including N-acetylglucosaminidases (EC 3.2.1.52), deacetylases (EC 3.5.1.25), and UDP-N-acetylglucosamine pyrophosphorylases (EC 2.7.7.23). This enzymatic network facilitates efficient conversion of chitin to N-acetylglucosamine monomers and downstream metabolites. The findings contribute to the understanding of <i>S. violaceoruber</i> BM-41 genomic features and its potential as a source of industrially relevant enzymes.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04634-6.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"28"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12705926/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145773224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Recent advances in hydroxynitrile lyase discovery, evolutionary history, recombinant expression and applications. 羟基腈裂解酶的发现、进化历史、重组表达及应用研究进展。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-26 DOI: 10.1007/s13205-025-04653-3
Asha Kumari, Monica Sharma

Hydroxynitrile lyases (HNLs) are stereoselective biocatalysts that catalyze the addition of hydrogen cyanide to carbonyl compounds, yielding enantiopure cyanohydrins-valuable intermediates in pharmaceutical and agrochemical synthesis. Recent advances have expanded our understanding of HNLs across multiple dimensions, including their evolutionary origins, structural diversity, and catalytic mechanisms. High-throughput screening methods have accelerated the discovery and functional assessment of novel HNLs from diverse biological sources, revealing enzymes from lipocalin, α + β barrel, and cupin superfamilies. Structural and mechanistic studies have elucidated active site architectures, enabling rational design and protein engineering for improved stability, substrate scope, and catalytic efficiency. Recombinant expression systems now support scalable production and purification, while immobilization techniques enhance enzyme reusability for industrial applications. HNLs have proven especially valuable in the asymmetric synthesis of cyanohydrins under mild, environmentally friendly conditions. This review highlights recent progress in HNL research, emphasizing innovations in enzyme discovery, engineering, and application, while outlining key challenges and future directions for integrating HNLs into sustainable biocatalytic processes.

Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04653-3.

羟基腈裂解酶(HNLs)是一种立体选择性生物催化剂,可催化羰基化合物与氰化氢的加成,生成对映纯氰基氢,是医药和农用化学品合成中有价值的中间体。最近的研究进展扩展了我们对hnl的理解,包括它们的进化起源、结构多样性和催化机制。高通量筛选方法加速了来自不同生物来源的新型hnl的发现和功能评估,揭示了来自脂钙蛋白、α + β桶和cupin超家族的酶。结构和机制研究已经阐明了活性位点结构,使合理设计和蛋白质工程能够提高稳定性,底物范围和催化效率。重组表达系统现在支持可扩展的生产和纯化,而固定化技术提高了酶在工业应用中的可重用性。hnl在温和、环保条件下的不对称氰醇合成中被证明是特别有价值的。本文综述了HNL研究的最新进展,强调了在酶的发现、工程和应用方面的创新,同时概述了将HNL整合到可持续生物催化过程中的主要挑战和未来方向。补充信息:在线版本包含补充资料,下载地址:10.1007/s13205-025-04653-3。
{"title":"Recent advances in hydroxynitrile lyase discovery, evolutionary history, recombinant expression and applications.","authors":"Asha Kumari, Monica Sharma","doi":"10.1007/s13205-025-04653-3","DOIUrl":"https://doi.org/10.1007/s13205-025-04653-3","url":null,"abstract":"<p><p>Hydroxynitrile lyases (HNLs) are stereoselective biocatalysts that catalyze the addition of hydrogen cyanide to carbonyl compounds, yielding enantiopure cyanohydrins-valuable intermediates in pharmaceutical and agrochemical synthesis. Recent advances have expanded our understanding of HNLs across multiple dimensions, including their evolutionary origins, structural diversity, and catalytic mechanisms. High-throughput screening methods have accelerated the discovery and functional assessment of novel HNLs from diverse biological sources, revealing enzymes from lipocalin, α + β barrel, and cupin superfamilies. Structural and mechanistic studies have elucidated active site architectures, enabling rational design and protein engineering for improved stability, substrate scope, and catalytic efficiency. Recombinant expression systems now support scalable production and purification, while immobilization techniques enhance enzyme reusability for industrial applications. HNLs have proven especially valuable in the asymmetric synthesis of cyanohydrins under mild, environmentally friendly conditions. This review highlights recent progress in HNL research, emphasizing innovations in enzyme discovery, engineering, and application, while outlining key challenges and future directions for integrating HNLs into sustainable biocatalytic processes.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04653-3.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"38"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12743048/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145848747","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of AI for the functional elucidation of rice associated microbial community for the improved productivity. 应用人工智能技术分析水稻相关微生物群落功能,提高水稻产量。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-05 DOI: 10.1007/s13205-025-04665-z
Jeevan Joyce, Priya V K, Jayachandran K, Radhakrishnan E K

Rice microbiome plays a critical role in the growth, health, stress tolerance, nutrient uptake, root development, and productivity of its host. In this study, advanced machine learning algorithms were applied to analyze the genomic data from 1365 rice-associated bacteria sourced from Bacterial and Viral Bioinformatics Resource Center (BV-BRC) database. After filtering, the genomic data of 280 organisms were selected and annotated to identify their respective genes. These were further categorized into ortholog groups, and based on the presence and absence of the ortholog groups, the organisms were clustered into eight groups. Genes encoding amino acid transport, inorganic ion transport and metabolism were the most common Clusters of Orthologous Genes (COG) categories observed across the various clusters while cellular process, biological regulation, and response to stimuli were the most common gene ontology terms. However, the presence of a large proportion of genes having unknown functions suggests the distribution of novel genes which could facilitate the functions including the plant colonization. Further to this, machine learning models were used to classify the organisms as either beneficial or pathogenic. Here, Support Vector Machine based analysis showed the highest accuracy (92.98%) when compared to the Logistic Regression (90.16%) and Random Forest (57.80%). From the analysis, ABC-type transporters such as ABC-type oligopeptide transport system were more abundantly distributed in beneficial bacteria. On the other hand, transposase such as Transposase InsA were observed to be common among pathogenic strains. From the results obtained, the presence of genes responsible for the nutrient transport and metabolic versatility was found to be significant for the beneficial bacteria, while the genetic variability was remarkable for the pathogens. The information generated in this study hence highlights the power of AI for predicting the beneficial interactions between the rice and its microbiome, and thereby offer its applications in enhancing the crop resilience and productivity for the sustainable agricultural practices.

Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04665-z.

水稻微生物组在寄主的生长、健康、胁迫耐受性、养分吸收、根系发育和生产力等方面起着关键作用。在这项研究中,应用先进的机器学习算法分析了来自细菌和病毒生物信息学资源中心(BV-BRC)数据库的1365种水稻相关细菌的基因组数据。筛选后,选择280种生物的基因组数据并进行注释,以鉴定其各自的基因。这些生物进一步被分类为同源群,并基于同源群的存在和缺失,将生物聚为8类。编码氨基酸转运、无机离子转运和代谢的基因是各基因簇中最常见的同源基因簇(COG)类别,而细胞过程、生物调控和对刺激的反应是最常见的基因本体术语。然而,大量功能未知的基因的存在表明,新基因的分布可能促进包括植物定殖在内的功能。此外,机器学习模型被用于将生物体分类为有益或致病。与Logistic回归(90.16%)和随机森林(57.80%)相比,基于支持向量机的分析显示出最高的准确率(92.98%)。从分析来看,abc型转运体如abc型寡肽转运系统在有益菌中的分布更为丰富。另一方面,在致病性菌株中普遍存在转座酶,如转座酶InsA。从所获得的结果来看,负责营养转运和代谢多样性的基因的存在对有益细菌来说是重要的,而对病原体来说则是显著的遗传变异性。因此,本研究中产生的信息突出了人工智能在预测水稻与其微生物群之间有益相互作用方面的力量,从而为可持续农业实践提供了提高作物抗逆性和生产力的应用。补充信息:在线版本包含补充资料,提供地址为10.1007/s13205-025-04665-z。
{"title":"Application of AI for the functional elucidation of rice associated microbial community for the improved productivity.","authors":"Jeevan Joyce, Priya V K, Jayachandran K, Radhakrishnan E K","doi":"10.1007/s13205-025-04665-z","DOIUrl":"https://doi.org/10.1007/s13205-025-04665-z","url":null,"abstract":"<p><p>Rice microbiome plays a critical role in the growth, health, stress tolerance, nutrient uptake, root development, and productivity of its host. In this study, advanced machine learning algorithms were applied to analyze the genomic data from 1365 rice-associated bacteria sourced from Bacterial and Viral Bioinformatics Resource Center (BV-BRC) database. After filtering, the genomic data of 280 organisms were selected and annotated to identify their respective genes. These were further categorized into ortholog groups, and based on the presence and absence of the ortholog groups, the organisms were clustered into eight groups. Genes encoding amino acid transport, inorganic ion transport and metabolism were the most common Clusters of Orthologous Genes (COG) categories observed across the various clusters while cellular process, biological regulation, and response to stimuli were the most common gene ontology terms. However, the presence of a large proportion of genes having unknown functions suggests the distribution of novel genes which could facilitate the functions including the plant colonization. Further to this, machine learning models were used to classify the organisms as either beneficial or pathogenic. Here, Support Vector Machine based analysis showed the highest accuracy (92.98%) when compared to the Logistic Regression (90.16%) and Random Forest (57.80%). From the analysis, ABC-type transporters such as ABC-type oligopeptide transport system were more abundantly distributed in beneficial bacteria. On the other hand, transposase such as Transposase InsA were observed to be common among pathogenic strains. From the results obtained, the presence of genes responsible for the nutrient transport and metabolic versatility was found to be significant for the beneficial bacteria, while the genetic variability was remarkable for the pathogens. The information generated in this study hence highlights the power of AI for predicting the beneficial interactions between the rice and its microbiome, and thereby offer its applications in enhancing the crop resilience and productivity for the sustainable agricultural practices.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04665-z.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"63"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770020/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916571","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IL27RA is a promising key target for statins in treating hyperlipidemia. IL27RA是他汀类药物治疗高脂血症的关键靶点。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-05 DOI: 10.1007/s13205-025-04668-w
Na Zhao, Yan Li, Yajie Liu

Statins are widely used in the treatment of hyperlipidemia; however, their specific mechanisms of action remain incompletely understood. To identify key therapeutic targets, we integrated differential expression analysis with machine learning and identified IL27RA as a pivotal candidate. IL27RA expression was significantly upregulated in atorvastatin-treated hyperlipidemia patients compared to healthy controls but decreased following statin intervention. Functional enrichment analysis revealed its association with immune-related pathways, and consistent with this, immune infiltration analysis showed significant correlations between IL27RA expression and the abundance of Th1 and plasmacytoid dendritic cells. Molecular docking and dynamics simulations further confirmed stable binding between IL27RA and atorvastatin. Collectively, these results establish IL27RA as a key therapeutic target for statins in hyperlipidemia and highlight its role in modulating the immune microenvironment.

Supplementary information: The online version contains supplementary material available at 10.1007/s13205-025-04668-w.

他汀类药物广泛用于治疗高脂血症;然而,它们的具体作用机制仍不完全清楚。为了确定关键的治疗靶点,我们将差异表达分析与机器学习结合起来,确定了IL27RA作为关键的候选靶点。与健康对照组相比,阿托伐他汀治疗的高脂血症患者il - 27ra表达显著上调,但他汀类药物干预后il - 27ra表达降低。功能富集分析显示其与免疫相关通路相关,与此一致的是,免疫浸润分析显示IL27RA的表达与Th1和浆细胞样树突状细胞的丰度存在显著相关性。分子对接和动力学模拟进一步证实了IL27RA与阿托伐他汀的稳定结合。总之,这些结果确立了IL27RA作为他汀类药物治疗高脂血症的关键靶点,并强调了其在调节免疫微环境中的作用。补充信息:在线版本包含补充资料,提供地址:10.1007/s13205-025-04668-w。
{"title":"IL27RA is a promising key target for statins in treating hyperlipidemia.","authors":"Na Zhao, Yan Li, Yajie Liu","doi":"10.1007/s13205-025-04668-w","DOIUrl":"https://doi.org/10.1007/s13205-025-04668-w","url":null,"abstract":"<p><p>Statins are widely used in the treatment of hyperlipidemia; however, their specific mechanisms of action remain incompletely understood. To identify key therapeutic targets, we integrated differential expression analysis with machine learning and identified IL27RA as a pivotal candidate. IL27RA expression was significantly upregulated in atorvastatin-treated hyperlipidemia patients compared to healthy controls but decreased following statin intervention. Functional enrichment analysis revealed its association with immune-related pathways, and consistent with this, immune infiltration analysis showed significant correlations between IL27RA expression and the abundance of Th1 and plasmacytoid dendritic cells. Molecular docking and dynamics simulations further confirmed stable binding between IL27RA and atorvastatin. Collectively, these results establish IL27RA as a key therapeutic target for statins in hyperlipidemia and highlight its role in modulating the immune microenvironment.</p><p><strong>Supplementary information: </strong>The online version contains supplementary material available at 10.1007/s13205-025-04668-w.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"51"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770107/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916574","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells. Talazoparib通过解除患者来源的口腔癌干细胞中P300和GCN5染色质重塑子的调控,增强了quinacrine的抗血管生成潜能。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2026-01-05 DOI: 10.1007/s13205-025-04670-2
Chinmay Das, Subarno Paul, Subhasmita Bhal, Sushree Subhadra Acharya, Somya Ranjan Dash, Aakash Goswami, Aashi Thakur, Pramod Chandra Pathy, Chanakya Nath Kundu, Tithi Parija

Angiogenesis plays a crucial role in cancer progression. However, the role of PARP1 in regulating chromatin remodelers and activating pro-angiogenic factors in cancer stem cells (CSCs) remains poorly understood. This study systematically investigates the detailed molecular mechanism through which PARP1 and its associated chromatin remodelers, P300 and GCN5, regulate angiogenesis in ex vivo patient-derived oral mucosa cancer stem cells (PD-OMCSCs). To investigate this mechanism, we used a combination of experimental approaches, including CAM assays, tube formation assays, biochemical analyses (western blot, gelatin zymography, and ELISA), molecular imaging (tissue immunofluorescence), and protein-protein interaction (co-immunoprecipitation and in silico study). Comparative analyses revealed significantly higher expression of PARP1, P300, and GCN5 in oral cancer tissues compared to normal ones. Co-immunoprecipitation and docking studies confirmed their mutual interactions, forming a chromatin-remodeling complex (PARP1-P300-GCN5) that facilitates angiogenic gene activation and expression. Quinacrine (QC), in combination with PARP inhibitor Talazoparib, disrupted this complex, leading to significant downregulation of VEGFA expression, reduced MMP activity, and suppression of angiogenic markers (Ang-1, Ang-2, TGF-β, CXCL-12, VEGFC, HIF-1α, and IL-6). These effects collectively impaired endothelial cell tube formation and blood vessel development in both HUVECs and CAM models. Furthermore, individual knockdown of PARP1, P300, or GCN5 reduced VEGFA expression, indicating their important role in regulating tumor angiogenesis. In conclusion, the QC and Talazoparib combination effectively prevents the activation and secretion of angiogenic factors, thereby suppressing angiogenesis, and may serve as a promising therapeutic approach for oral cancer by targeting PARP1 and associated chromatin remodelers.

血管生成在癌症进展中起着至关重要的作用。然而,PARP1在癌症干细胞(CSCs)中调节染色质重塑和激活促血管生成因子中的作用仍然知之甚少。本研究系统地探讨了PARP1及其相关的染色质重塑子P300和GCN5调控体外患者源性口腔黏膜癌干细胞(PD-OMCSCs)血管生成的详细分子机制。为了研究这一机制,我们使用了多种实验方法,包括CAM测定、试管形成测定、生化分析(western blot、明胶酶谱法和ELISA)、分子成像(组织免疫荧光)和蛋白质-蛋白质相互作用(共免疫沉淀和硅研究)。对比分析显示,PARP1、P300和GCN5在口腔癌组织中的表达明显高于正常组织。共免疫沉淀和对接研究证实了它们之间的相互作用,形成染色质重塑复合物(PARP1-P300-GCN5),促进血管生成基因的激活和表达。Quinacrine (QC)与PARP抑制剂Talazoparib联合可破坏该复合物,导致VEGFA表达显著下调,MMP活性降低,血管生成标志物(Ang-1、Ang-2、TGF-β、CXCL-12、VEGFC、HIF-1α和IL-6)抑制。在HUVECs和CAM模型中,这些影响共同损害了内皮细胞管的形成和血管的发育。此外,个体敲低PARP1、P300或GCN5可降低VEGFA的表达,表明它们在调节肿瘤血管生成中起重要作用。综上所述,QC和Talazoparib联合使用可以有效阻止血管生成因子的激活和分泌,从而抑制血管生成,可能是一种有希望的治疗口腔癌的方法,通过靶向PARP1和相关的染色质重塑蛋白。
{"title":"Talazoparib enhances the anti-angiogenic potential of quinacrine through the deregulation of P300 and GCN5 chromatin remodelers in patient-derived oral cancer stem cells.","authors":"Chinmay Das, Subarno Paul, Subhasmita Bhal, Sushree Subhadra Acharya, Somya Ranjan Dash, Aakash Goswami, Aashi Thakur, Pramod Chandra Pathy, Chanakya Nath Kundu, Tithi Parija","doi":"10.1007/s13205-025-04670-2","DOIUrl":"https://doi.org/10.1007/s13205-025-04670-2","url":null,"abstract":"<p><p>Angiogenesis plays a crucial role in cancer progression. However, the role of PARP1 in regulating chromatin remodelers and activating pro-angiogenic factors in cancer stem cells (CSCs) remains poorly understood. This study systematically investigates the detailed molecular mechanism through which PARP1 and its associated chromatin remodelers, P300 and GCN5, regulate angiogenesis in ex vivo patient-derived oral mucosa cancer stem cells (PD-OMCSCs). To investigate this mechanism, we used a combination of experimental approaches, including CAM assays, tube formation assays, biochemical analyses (western blot, gelatin zymography, and ELISA), molecular imaging (tissue immunofluorescence), and protein-protein interaction (co-immunoprecipitation and in silico study). Comparative analyses revealed significantly higher expression of PARP1, P300, and GCN5 in oral cancer tissues compared to normal ones. Co-immunoprecipitation and docking studies confirmed their mutual interactions, forming a chromatin-remodeling complex (PARP1-P300-GCN5) that facilitates angiogenic gene activation and expression. Quinacrine (QC), in combination with PARP inhibitor Talazoparib, disrupted this complex, leading to significant downregulation of VEGFA expression, reduced MMP activity, and suppression of angiogenic markers (Ang-1, Ang-2, TGF-β, CXCL-12, VEGFC, HIF-1α, and IL-6). These effects collectively impaired endothelial cell tube formation and blood vessel development in both HUVECs and CAM models. Furthermore, individual knockdown of PARP1, P300, or GCN5 reduced VEGFA expression, indicating their important role in regulating tumor angiogenesis. In conclusion, the QC and Talazoparib combination effectively prevents the activation and secretion of angiogenic factors, thereby suppressing angiogenesis, and may serve as a promising therapeutic approach for oral cancer by targeting PARP1 and associated chromatin remodelers.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"49"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12770163/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Formulation and in vitro evaluation of lipid-polymer hybrid nanoparticles for targeted delivery of gemcitabine hydrochloride in the treatment of hepatocellular carcinoma. 靶向递送盐酸吉西他滨治疗肝细胞癌的脂质-聚合物杂化纳米颗粒的制备及体外评价
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-01 DOI: 10.1007/s13205-025-04628-4
Swati Dubey, Sanjeev Kumar Patel, Chinmay Das, Shalini Singh, Geetika Sharma, Chanakya Nath Kundu, Sunita Minz

This investigation was intended to prepare lipid-polymer hybrid nanoparticles (LPHNPs) that are laden with Gemcitabine hydrochloride (GEM) for the controlled delivery to treat Hepatocellular carcinoma (HCC). LPHNPs were developed by the solvent evaporation technique employing polycaprolactone (PCL) as the biodegradable polymeric core and a phospholipid shell comprised of soya phosphatidylcholine (SPC) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE). This study presents a cost-effective, simple method for functionalizing LPHNPs with the carbohydrate ligand D-galactose (GA) using stearyl amine (SA) as a linker. To examine the impact of three independent factors on the particle size, percent entrapment efficiency (% EE), and percent drug loading (% DL), a three-factor, three-level Box-Behnken design (BBD) was implemented with Design-Expert 13 software. The nanoparticles' size range increased from 194.1 to 505.3 nm when the polymer content increased. GEM's percent drug release profile in the galactose functionalized gemcitabine-loaded lipid-polymer hybrid nanoparticles (GEM-LPHNPs-GA) suggests they are appropriate candidates for targeting the tumors microenvironment. In vitro drug release tests revealed a higher GEM release at pH 5.5 compared to the physiological pH of 7.4 for 48 h. Fourier transform infrared spectroscopy (FTIR) and proton nuclear magnetic resonance (1H-NMR) spectroscopy verified that the conjugate GA-SA imine bond formed. The cytotoxicity of GEM-LPHNPs-GA was significantly greater than that of GEM-LPHNPs or GEM alone, as evidenced by the MTT assay conducted on HepG2 cells. Throughout the incubation period, HepG2 cells exhibit a markedly higher absorption of dye-loaded LPHNPs-GA than LPHNPs. GEM-LPHNPs-GA is an efficacious formulation for the targeted administration of anti-cancer therapeutics.

本研究旨在制备载盐酸吉西他滨(GEM)的脂质-聚合物混合纳米颗粒(LPHNPs),用于控制递送治疗肝细胞癌(HCC)。采用溶剂蒸发技术,以聚己内酯(PCL)为可生物降解聚合物核,以大豆磷脂酰胆碱(SPC)和1,2-二硬脂酰-sn-甘油-3-磷酸乙醇胺(DSPE)为磷脂壳,制备了LPHNPs。本研究提出了一种经济、简单的方法,利用硬脂酰胺(SA)作为连接剂,用碳水化合物配体d -半乳糖(GA)功能化LPHNPs。为了检验三个独立因素对粒径、包封率(% EE)和载药量(% DL)的影响,采用design - expert 13软件进行了三因素、三水平的Box-Behnken设计(BBD)。随着聚合物含量的增加,纳米颗粒的尺寸范围从194.1 nm增大到505.3 nm。GEM在半乳糖功能化的负载吉西他滨的脂质-聚合物混合纳米颗粒(GEM- lphnps - ga)中的药物释放百分比表明它们是靶向肿瘤微环境的合适候选药物。体外药物释放实验显示,在pH为5.5时,GEM的释放量高于生理pH为7.4的释放48 h。傅里叶变换红外光谱(FTIR)和质子核磁共振(1H-NMR)光谱验证了GA-SA共轭亚胺键的形成。在HepG2细胞上的MTT实验证明,GEM- lphnps - ga的细胞毒性明显大于GEM- lphnps或GEM单独使用。在整个孵育期间,HepG2细胞对负载染料的LPHNPs- ga的吸收明显高于LPHNPs。GEM-LPHNPs-GA是一种有效的靶向抗癌治疗制剂。
{"title":"Formulation and in vitro evaluation of lipid-polymer hybrid nanoparticles for targeted delivery of gemcitabine hydrochloride in the treatment of hepatocellular carcinoma.","authors":"Swati Dubey, Sanjeev Kumar Patel, Chinmay Das, Shalini Singh, Geetika Sharma, Chanakya Nath Kundu, Sunita Minz","doi":"10.1007/s13205-025-04628-4","DOIUrl":"10.1007/s13205-025-04628-4","url":null,"abstract":"<p><p>This investigation was intended to prepare lipid-polymer hybrid nanoparticles (LPHNPs) that are laden with Gemcitabine hydrochloride (GEM) for the controlled delivery to treat Hepatocellular carcinoma (HCC). LPHNPs were developed by the solvent evaporation technique employing polycaprolactone (PCL) as the biodegradable polymeric core and a phospholipid shell comprised of soya phosphatidylcholine (SPC) and 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE). This study presents a cost-effective, simple method for functionalizing LPHNPs with the carbohydrate ligand D-galactose (GA) using stearyl amine (SA) as a linker. To examine the impact of three independent factors on the particle size, percent entrapment efficiency (% EE), and percent drug loading (% DL), a three-factor, three-level Box-Behnken design (BBD) was implemented with Design-Expert 13 software. The nanoparticles' size range increased from 194.1 to 505.3 nm when the polymer content increased. GEM's percent drug release profile in the galactose functionalized gemcitabine-loaded lipid-polymer hybrid nanoparticles (GEM-LPHNPs-GA) suggests they are appropriate candidates for targeting the tumors microenvironment. In vitro drug release tests revealed a higher GEM release at pH 5.5 compared to the physiological pH of 7.4 for 48 h. Fourier transform infrared spectroscopy (FTIR) and proton nuclear magnetic resonance (<sup>1</sup>H-NMR) spectroscopy verified that the conjugate GA-SA imine bond formed. The cytotoxicity of GEM-LPHNPs-GA was significantly greater than that of GEM-LPHNPs or GEM alone, as evidenced by the MTT assay conducted on HepG2 cells. Throughout the incubation period, HepG2 cells exhibit a markedly higher absorption of dye-loaded LPHNPs-GA than LPHNPs. GEM-LPHNPs-GA is an efficacious formulation for the targeted administration of anti-cancer therapeutics.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"2"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12665642/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145659812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Saline petroleum refinery wastewater treatment integrated with bioelectricity production using halophiles in microbial fuel cell (MFC). 微生物燃料电池(MFC)中亲盐菌处理含盐炼油废水与生物发电相结合。
IF 2.9 4区 生物学 Q3 BIOTECHNOLOGY & APPLIED MICROBIOLOGY Pub Date : 2026-01-01 Epub Date: 2025-12-02 DOI: 10.1007/s13205-025-04618-6
Arulazhagan Pugazhendi

Petroleum refinery wastewater (PRWW) with 4% salinity was subjected to treatment and simultaneous generation of energy in air cathode-microbial fuel cell (MFC). Substrate load (SL) such as 0.41 gCOD/L, 0.84 gCOD/L, 1.26 gCOD/L, 1.78 gCOD/L and 2.25 gCOD/L was trialed in air cathode MFC. COD (chemical oxygen demand) reduction was 88% (total COD) and 87% (soluble COD) at optimized SL of 1.78 gCOD/L. Corresponding power and current density derived at optimized SL of 1.78 gCOD/L was 879 mW/m2 and 1052 mA/m2 respectively. Degradation of low and high molecular weight petroleum hydrocarbons in the PRWW was greater than 90% to 100%  and 71% to 82% respectively. Supplementation with a mild nutritional substrate in PRWW accelerated the hydrocarbon biodegradation with time reduction in MFC operated at 1.78 gCOD/L SL. Phylogenetic analysis revealed the dominancy of exo-electrogenic halophilic strains such as Ochrobactrum, Marinobacter, Bacillus and Stenotrophomonas in the reactor. Thus the bioaugmentation of halophiles in MFC efficiently treated PRWW and harvested bioenergy under saline condition.

在空气阴极-微生物燃料电池(MFC)中对含盐量为4%的炼油废水进行了处理并同步发电。在空气阴极MFC中试验了0.41、0.84、1.26、1.78和2.25 gCOD/L的衬底负荷(SL)。在优化投加量为1.78 gCOD/L时,总COD和可溶性COD分别降低88%和87%。在1.78 gCOD/L的优化SL下,相应的功率和电流密度分别为879 mW/m2和1052 mA/m2。PRWW对低分子量和高分子量石油烃的降解率分别大于90% ~ 100%和71% ~ 82%。在运行于1.78 gCOD/L SL的MFC中,在PRWW中添加轻度营养底物加速了烃类的生物降解,并缩短了降解时间。系统发育分析显示,反应器中外电生嗜盐菌(Ochrobactrum)、Marinobacter、芽孢杆菌(Bacillus)和窄养单胞菌(Stenotrophomonas)占主导地位。因此,MFC中嗜盐菌的生物强化有效地处理了PRWW,并在盐水条件下收获了生物能。
{"title":"Saline petroleum refinery wastewater treatment integrated with bioelectricity production using halophiles in microbial fuel cell (MFC).","authors":"Arulazhagan Pugazhendi","doi":"10.1007/s13205-025-04618-6","DOIUrl":"https://doi.org/10.1007/s13205-025-04618-6","url":null,"abstract":"<p><p>Petroleum refinery wastewater (PRWW) with 4% salinity was subjected to treatment and simultaneous generation of energy in air cathode-microbial fuel cell (MFC). Substrate load (SL) such as 0.41 gCOD/L, 0.84 gCOD/L, 1.26 gCOD/L, 1.78 gCOD/L and 2.25 gCOD/L was trialed in air cathode MFC. COD (chemical oxygen demand) reduction was 88% (total COD) and 87% (soluble COD) at optimized SL of 1.78 gCOD/L. Corresponding power and current density derived at optimized SL of 1.78 gCOD/L was 879 mW/m<sup>2</sup> and 1052 mA/m<sup>2</sup> respectively. Degradation of low and high molecular weight petroleum hydrocarbons in the PRWW was greater than 90% to 100%  and 71% to 82% respectively. Supplementation with a mild nutritional substrate in PRWW accelerated the hydrocarbon biodegradation with time reduction in MFC operated at 1.78 gCOD/L SL. Phylogenetic analysis revealed the dominancy of exo-electrogenic halophilic strains such as <i>Ochrobactrum</i>, <i>Marinobacter</i>, <i>Bacillus</i> and <i>Stenotrophomonas</i> in the reactor. Thus the bioaugmentation of halophiles in MFC efficiently treated PRWW and harvested bioenergy under saline condition.</p>","PeriodicalId":7067,"journal":{"name":"3 Biotech","volume":"16 1","pages":"4"},"PeriodicalIF":2.9,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12672978/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145676041","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"生物学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
3 Biotech
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1